ArticleArchives of microbiology2026
Integrated nanoemulsion based functional feed against Vibrio parahaemolyticus pathogenesis in Penaeus vannamei: physicochemical characterization and in vivo efficacy.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The global production of Penaeus vannamei shrimp is threatened by Vibrio parahaemolyticus, a pathogen causing severe disease outbreaks and economic losses, especially in Asia. This study developed and characterized stable sunflower oil-based nanoemulsions (NEs) and incorporated them into formulated feed for targeted antimicrobial control. Physicochemical analyses (particle size, zeta potential, viscosity, stability) confirmed uniform formulations. Antimicrobial efficacy was evaluated using MIC/MBC, adherence, biofilm inhibition, oxygen consumption rate (OCR), and virulence gene expression assays. NE-23 and NE-27 showed strong antibacterial activity (MIC/MBC: 1-256/2-170 µg/mL), consistent with gentamicin. NE-22 exhibited the highest anti-adherence activity (70.62%), while NE-23 and NE-21 were most effective against pathogenic strains. Biofilm inhibition reached 72.17% (NE-22, MTCC-451) and 59-60% (NE-23, shrimp isolates), comparable to gentamicin. Dead cell assays revealed NE-24 induced up to 68.52% mortality, surpassing gentamicin in some strains. OCR analysis showed greater inhibition by NE-22 (0.31-fold reduction) than gentamicin (0.66-fold). Gene expression profiling demonstrated relative downregulation by NE-23. Finally, nanoemulsion-infused formulated feed conferred in vivo protection against V. parahaemolyticus without affecting shrimp growth or survival. Overall, NE-22 and NE-23 emerged as potent antibiotic alternatives, offering a sustainable strategy to mitigate V. parahaemolyticus infections in shrimp aquaculture.
Indexed as
Identifiers
41843119What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.